<?xml version="1.0" encoding="UTF-8"?>
<iati-activities version="2.03">
 <iati-activity default-currency="USD" hierarchy="2" humanitarian="0" iati-activities:version="2.03" xml:lang="FR" xmlns:iati-activities="http://d-portal.org/xmlns/iati-activities" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <iati-identifier>XM-DAC-41114-OUTPUT-00098605</iati-identifier>
  <reporting-org ref="XM-DAC-41114" type="40">
   <narrative xml:lang="FR">United Nations Development Programme</narrative>
  </reporting-org>
  <title>
   <narrative xml:lang="FR">Support National TB&amp;HIV Progra</narrative>
  </title>
  <description type="1">
   <narrative xml:lang="FR">The main objective of this project is to improve access to care and quality of care for TB patients including the most vulnerable including children, refugees, and prisoners</narrative>
  </description>
  <participating-org ref="47045" role="1">
   <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41114" role="1">
   <narrative xml:lang="FR">UNITED NATIONS DEVELOPMENT PROGRAMME</narrative>
  </participating-org>
  <participating-org ref="XM-DAC-41114" role="4" type="40">
   <narrative xml:lang="FR">United Nations Development Programme</narrative>
  </participating-org>
  <activity-status code="2"></activity-status>
  <activity-date iso-date="2016-01-01" type="1"></activity-date>
  <activity-date iso-date="2016-01-01" type="2"></activity-date>
  <activity-date iso-date="2020-12-31" type="3"></activity-date>
  <contact-info type="1">
   <email>registry.dj@undp.org</email>
   <website>http://www.dj.undp.org/</website>
  </contact-info>
  <activity-scope code="8"></activity-scope>
  <recipient-country code="DJ" percentage="100">
   <narrative xml:lang="FR">Djibouti</narrative>
  </recipient-country>
  <location ref="DJ">
   <location-reach code="2"></location-reach>
   <location-id code="223817" vocabulary="G1"></location-id>
   <name>
    <narrative xml:lang="FR">Djibouti</narrative>
   </name>
   <description>
    <narrative xml:lang="FR">capital of a political entity</narrative>
   </description>
   <activity-description>
    <narrative xml:lang="FR">Support National TB&amp;HIV Programmes to increase treatment</narrative>
   </activity-description>
   <administrative code="223817" level="1" vocabulary="G1"></administrative>
   <point srsName="http://www.opengis.net/def/crs/EPSG/0/4326">
    <pos>11.589010 43.145030</pos>
   </point>
   <exactness code="1"></exactness>
   <location-class code="2"></location-class>
   <feature-designation code="PPLC"></feature-designation>
  </location>
  <sector code="17" percentage="100" vocabulary="99">
   <narrative xml:lang="FR">Eradicate poverty in all its forms and dimensions</narrative>
  </sector>
  <sector code="16050" percentage="100" vocabulary="1"></sector>
  <sector code="3.3" percentage="100" vocabulary="8"></sector>
  <tag code="3.3" vocabulary="3"></tag>
  <policy-marker code="1" significance="2" vocabulary="1"></policy-marker>
  <collaboration-type code="4"></collaboration-type>
  <default-flow-type code="10"></default-flow-type>
  <default-finance-type code="110"></default-finance-type>
  <default-aid-type code="C01" vocabulary="1"></default-aid-type>
  <default-tied-status code="5"></default-tied-status>
  <budget status="2" type="2">
   <period-start iso-date="2016-01-01"></period-start>
   <period-end iso-date="2016-12-31"></period-end>
   <value currency="USD" value-date="2016-12-31">3519601</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2017-01-01"></period-start>
   <period-end iso-date="2017-12-31"></period-end>
   <value currency="USD" value-date="2017-12-31">4382004</value>
  </budget>
  <budget status="2" type="2">
   <period-start iso-date="2018-01-01"></period-start>
   <period-end iso-date="2018-12-31"></period-end>
   <value currency="USD" value-date="2018-12-31">1142657</value>
  </budget>
  <capital-spend percentage="0"></capital-spend>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="USD" value-date="2016-12-31">4465715</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="USD" value-date="2016-12-31">3519601</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="USD" value-date="2017-12-31">2752176</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="USD" value-date="2017-12-31">4364537</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="1"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="USD" value-date="2018-12-31">172946</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="USD" value-date="2018-12-31">1142657</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">1</value>
   <provider-org provider-activity-id="47045-DJI-C-UNDP" ref="47045">
    <narrative xml:lang="FR">GLOBAL FUND TO FIGHT AIDS, TUBERCULOSIS</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="11"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="USD" value-date="2017-12-31">17467</value>
   <provider-org ref="XM-DAC-41114">
    <narrative xml:lang="FR">UNITED NATIONS DEVELOPMENT PROGRAMME</narrative>
   </provider-org>
   <receiver-org receiver-activity-id="XM-DAC-41114-OUTPUT-00098605" ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </receiver-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2016-12-31"></transaction-date>
   <value currency="USD" value-date="2016-12-31">2543982</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2017-12-31"></transaction-date>
   <value currency="USD" value-date="2017-12-31">3309882</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2018-12-31"></transaction-date>
   <value currency="USD" value-date="2018-12-31">1355125</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="4"></transaction-type>
   <transaction-date iso-date="2019-12-31"></transaction-date>
   <value currency="USD" value-date="2019-12-31">-945</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <transaction>
   <transaction-type code="2"></transaction-type>
   <transaction-date iso-date="2021-12-31"></transaction-date>
   <value currency="USD" value-date="2021-12-31">7208044</value>
   <provider-org ref="XM-DAC-41114" type="40">
    <narrative xml:lang="FR">United Nations Development Programme</narrative>
   </provider-org>
   <disbursement-channel code="2"></disbursement-channel>
  </transaction>
  <document-link format="TEXT/HTML" url="http://open.undp.org/projects/00094487">
   <title>
    <narrative xml:lang="FR">Activity web page</narrative>
   </title>
   <category code="A12"></category>
  </document-link>
  <related-activity ref="XM-DAC-41114-PROJECT-00094487" type="1"></related-activity>
  <conditions attached="0"></conditions>
  <result aggregation-status="1" type="1">
   <title>
    <narrative xml:lang="FR">Annual Output Results</narrative>
   </title>
   <indicator ascending="0" measure="1">
    <title>
     <narrative xml:lang="FR">Output Indicator</narrative>
    </title>
    <description>
     <narrative xml:lang="FR">TB prevalence rate (per 100,000 population )
Percentage of young people aged 15&#x2013;24 who are living with HIV  ( applicable only for 2016)
Estimate of the percentage of HIV infections among the children of HIV-positive women who have given birth in the preceding 12 months  (applicable only for 2016 ) 
Percentage of sex workers who are living with HIV : 
Case notification rate per 100,000 population- bacteriologically-confirmed TB, new and relapse (applicable only for 2016)
Treatment success rate of MDR-TB: Percentage of bacteriologically confirmed drug resistant TB cases (RR-TB and/or MDR-TB) successfully treated 
Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy 
Percentage of sex workers reporting the use of a condom with their most recent client  (applicable only for 2016)
TB treatment success rate: Percentage of TB cases resistant to rifampicin and/or multi-drug resistant which have been bacteriologically confirmed and successfully treated  SHORT-COURSE TREATMENT (applicable only for 2016)
Number of notified cases of bacteriologically confirmed TB, new and relapses 
Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period 
Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals (applicable only for 2016)
Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period (applicable only for 2016)
Number of children &lt;5 in contact with TB patients who began IPT (applicable only for 2016)
Percentage of TB patients who had an HIV test result recorded in the TB register (applicable only for 2016)
Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatm</narrative>
    </description>
    <baseline year="2016">
     <comment>
      <narrative xml:lang="FR">TB prevalence rate (per 100,000 population : 906/100 000 
Percentage of young people aged 15&#x2013;24 who are living with HIV : 1.5%
Estimate of the percentage of HIV infections among the children of HIV-positive women who have given birth in the preceding 12 months : 19.15%
Percentage of sex workers who are living with HIV : 13%
Case notification rate per 100,000 population- bacteriologically-confirmed TB, new and relapse : 132/100 000
Treatment success rate of MDR-TB: Percentage of bacteriologically confirmed drug resistant TB cases (RR-TB and/or MDR-TB) successfully treated : ND
Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy: 75.5%
Percentage of sex workers reporting the use of a condom with their most recent client : 71%
TB treatment success rate: Percentage of TB cases resistant to rifampicin and/or multi-drug resistant which have been bacteriologically confirmed and successfully treated  SHORT-COURSE TREATMENT: ND
Number of notified cases of bacteriologically confirmed TB, new and relapses : 1241
Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period :82.2%
Percentage of notified TB cases, all forms, contributed by non-NTP providers - community referrals : ND
Percentage of laboratories showing adequate performance in external quality assurance for smear microscopy among the total number of laboratories that undertake smear microscopy during the reporting period : 100%
Number of children &lt;5 in contact with TB patients who began IPT: ND
Percentage of TB patients who had an HIV test result recorded in the TB register : 83.4%
Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment : 77.3 %
Percentage of HIV-positive patients who were screened for TB in HIV care or treatment settings : ND
Percentage of new HIV-positive pat</narrative>
     </comment>
    </baseline>
    <period>
     <period-start iso-date="2018-01-01"></period-start>
     <period-end iso-date="2018-12-31"></period-end>
     <target>
      <comment>
       <narrative xml:lang="FR">Cibles de lextension (Janvier-Juin 2018)
TB prevalence rate (per 100,000 population : no target 
Percentage of sex workers who are living with HIV : no target 
Treatment success rate of MDR-TB: Percentage of bacteriologically confirmed drug resistant TB cases (RR-TB and/or MDR-TB) successfully treated : no target 
Percentage of adults and children with HIV known to be on treatment 12 months after initiation of antiretroviral therapy : no target 
Number of notified cases of bacteriologically confirmed TB, new and relapses : 809
Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period : 87.2%
Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment : 90%
Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that began second-line treatment : 46
Percentage of MSM reached with HIV prevention programs - defined package of services : no target 
Percentage of sex workers reached with HIV prevention programs - defined package of services : no target 
Percentage of people living with HIV currently receiving antiretroviral therapy among all adults and children living with HIV : 36.1% 
 Pourcentage dadultes et denfants qui ont commenc&#xE9; la th&#xE9;rapie antir&#xE9;trovirale, avec une charge virale ind&#xE9;tectable &#xE0; 12 mois (&lt;1000 copies/ml) : 79.8%
Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission: 65%</narrative>
      </comment>
     </target>
     <actual>
      <comment>
       <narrative xml:lang="FR">R&#xE9;sultats Extension Janvier-Juin 2018                                                              
Number of notified cases of bacteriologically confirmed TB, new and relapses : 529
Percentage of bacteriologically confirmed TB cases successfully treated (cured plus completed treatment) among the bacteriologically confirmed TB cases registered during a specified period :79.45%
Percentage of HIV-positive registered TB patients given anti-retroviral therapy during TB treatment :73.84%
Number of cases with drug resistant TB (RR-TB and/or MDR-TB) that began second-line treatment : 23 
Percentage of people living with HIV currently receiving antiretroviral therapy among all adults and children living with HIV : 31.03%
 Pourcentage dadultes et denfants qui ont commenc&#xE9; la th&#xE9;rapie antir&#xE9;trovirale, avec une charge virale ind&#xE9;tectable &#xE0; 12 mois (&lt;1000 copies/ml) : 46.66%
Percentage of HIV-positive pregnant women who received antiretrovirals to reduce the risk of mother-to-child transmission:87.50%</narrative>
      </comment>
     </actual>
    </period>
   </indicator>
  </result>
 </iati-activity>
</iati-activities>
